Norinchukin Bank The raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 24.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 175,935 shares of the healthcare conglomerate’s stock after buying an additional 34,618 shares during the period. UnitedHealth Group comprises 0.7% of Norinchukin Bank The’s investment portfolio, making the stock its 20th biggest position. Norinchukin Bank The’s holdings in UnitedHealth Group were worth $32,622,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group during the second quarter worth about $110,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth about $121,000. Kings Point Capital Management boosted its holdings in UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the last quarter. Finally, Jacobi Capital Management LLC boosted its holdings in UnitedHealth Group by 6.6% in the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock valued at $136,000 after purchasing an additional 45 shares during the last quarter. 86.20% of the stock is owned by institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $0.15 during trading hours on Wednesday, reaching $219.94. 2,397,446 shares of the company were exchanged, compared to its average volume of 3,116,121. The firm has a market cap of $214,570.92, a PE ratio of 23.07, a P/E/G ratio of 1.64 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Incorporated has a 12-month low of $156.09 and a 12-month high of $231.77.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the prior year, the business earned $2.17 EPS. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the completion of the transaction, the director now owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 62,606 shares of company stock valued at $12,677,525 in the last 90 days. Company insiders own 0.89% of the company’s stock.
UNH has been the topic of several recent analyst reports. Cowen reiterated an “outperform” rating and issued a $220.00 target price (up from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Jefferies Group restated a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a report on Friday, August 18th. UBS reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, August 29th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $224.56.
TRADEMARK VIOLATION WARNING: This report was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://ledgergazette.com/2017/12/07/norinchukin-bank-the-has-32-62-million-stake-in-unitedhealth-group-incorporated-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.